Canadian Pharmaceuticals & Biotech Most Popular Stocks

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

Terranueva

Market Cap: CA$1.4m

Terranueva Corporation intends to produce cannabis for medical and recreational purposes.

Waverley Pharma

Market Cap: CA$1.4m

A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom.

Pharmadrug

Market Cap: CA$1.3m

Operates as a specialty pharmaceutical company.

RAMM Pharma

Market Cap: CA$1.2m

Operates in the pharmaceutical and medical product business in Uruguay and Poland.

Nirvana Life Sciences

Market Cap: CA$1.1m

Engages in the research and development of therapeutic products and medicines to address addiction.

Adastra Holdings

Market Cap: CA$1.1m

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.

SOL Global Investments

Market Cap: CA$1.1m

A private equity firm specializing in emerging growth.

HAVN Life Sciences

Market Cap: CA$859.4k

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

Lumiera Health

Market Cap: CA$849.8k

Develops and commercializes evidence-based botanical products for the healthcare in Canada.

Lophos Holdings

Market Cap: CA$858.6k

Through its subsidiaries, engages in the cultivation and research of peyote cactus.

Entheon Biomedical

Market Cap: CA$831.5k

Operates as a biotechnology research and development company.

EGF Theramed Health

Market Cap: CA$813.2k

Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.

Ovation Science

Market Cap: CA$768.2k

Engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States.

Captor Capital

Market Cap: CA$767.1k

Engages in the retail sale of cannabis products in the United States.

Aequus Pharmaceuticals

Market Cap: CA$663.2k

Operates as a specialty pharmaceutical company in Canada.

Vaxil Bio

Market Cap: CA$617.5k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

Asia Green Biotechnology

Market Cap: CA$543.7k

Does not have significant operations.

Molecule Holdings

Market Cap: CA$488.9k

Engages in production and co-packing of cannabis-infused beverages in Canada.

Many Bright Ideas Technologies

Market Cap: CA$431.4k

Does not have significant operations.

ChitogenX

Market Cap: CA$415.6k

An orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada.

Xebra Brands

Market Cap: CA$420.7k

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

Albert Labs International

Market Cap: CA$372.1k

A biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom.

Wesana Health Holdings

Market Cap: CA$349.6k

Does not have significant operations.

Cytophage Technologies

Market Cap: CA$338.4k

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

NAVCO Pharmaceuticals

Market Cap: CA$285.3k

Develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada.

Digicann Ventures

Market Cap: CA$240.6k

Does not have significant operations.

NanoSphere Health Sciences

Market Cap: CA$205.5k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.